Published in Cancer Weekly, January 11th, 2011
"Of all patients with T1/T2 LC, who received primary RI between 1999 and 2007, the following characteristics were recorded: sex, age, TNM classification, tumour location, radiation schedule,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2011-01-11)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.